Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

Oyama N, Takahara N, Hasegawa Y, Tanase K, Miwa Y, Akino H, Okazawa H, Kudo T, Fujibayashi Y, Yokoyama O

  • KMID: 1447599
  • Nucl Med Mol Imaging.
  • 2011 Sep;45(3):217-219.
Although sunitinib shows a high response rate in patients with untreated metastatic renal cell carcinoma (mRCC), quite a few patients show no therapeutic effect. Therefore, it is crucial to distinguish...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Portal bifurcation reconstruction using own hepatic vein grafts due to portal vein anomaly of the living donor for the patient with portal vein thrombosis

Umemura A, Nitta H, Takahara T, Hasegawa Y, Katagiri H, Kanno S, Kobayashi M, Ando T, Kimura T, Sasaki A

A 57-year-old Japanese female was considered for living donor liver transplantation (LDLT) due to end-stage liver cirrhosis caused by primary biliary cholangitis with portal vein thrombosis (PVT) formation. A 26-year-old...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of native liver derived ECM-gel to develop a novel approach for orthotopic hepatocyte transplantation

Udagawa D, Yagi H, Nishi K, Nagata S, Hasegawa Y, Abe Y, Kitago M, Kitagawa Y

Background: In conventional, hepatocytes have been injected via portal vein or directly into liver parenchyma for cell transplantation, however this methodology could not provide efficient cell survival or function in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)

Nogami Y, Komatsu H, Makabe T, Hasegawa Y, Yokoyama Y, Kawana K, Okamoto A, Mikami M, Katabuchi H, The COVID-19 Task Force of the Japan Society of Gynecologic Oncology

Objective As coronavirus disease 2019 (COVID-19) rages on, it is a challenging task to balance resources for treatment of COVID-19 and malignancy-based treatment. For the development of optimal strategies, assessing the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr